| Symbol | ABSI |
|---|---|
| Name | ABSCI CORP |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Services-Commercial Physical & Biological Research |
| Address | 18105 SE MILL PLAIN BLVD, VANCOUVER, WA 98683 |
| Telephone | (360) 949-1041 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001672688 |
| Description | None |
Director Szela Mary T 🟢 acquired 12.9K shares of Absci Corp (ABSI) at $11.54 Transaction Date: Jun 30, 2026 | Filing ID: 000124
Read moreNew Form 424B5 - Absci Corp <b>Filed:</b> 2026-06-24 <b>AccNo:</b> 0001193125-26-281131 <b>Size:</b> 489 KB
Read moreAbsci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
Read more(19% Negative) ABSCI CORP (ABSI) Announces Delay in data Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment
Read moreAbsci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)
Read moreNew Form 4/A - Absci Corp <b>Filed:</b> 2026-06-15 <b>AccNo:</b> 0001672688-26-000116 <b>Size:</b> 8 KB
Read moreDirector MCGINNIS KAREN K 🟢 acquired 49.9K shares (1 derivative) of Absci Corp (ABSI) at $7.34 Transaction Date: Jun 04, 2026 | Filing ID: 000113
Read moreDirector Szela Mary T 🟢 acquired 49.9K shares (1 derivative) of Absci Corp (ABSI) at $7.34 Transaction Date: Jun 04, 2026 | Filing ID: 000526
Read moreDirector Pangalos Menelas N 🟢 acquired 49.9K shares (1 derivative) of Absci Corp (ABSI) at $7.34 Transaction Date: Jun 04, 2026 | Filing ID: 000109
Read more